Evaluating the metformin use on type 2 diabetes prevention in high-risk populations in primary care
Almost one out of two patients with a high risk of type 2 diabetes are not treated with metformin as a preventive measure. Factors associated with metformin prescription included a high BMI, elevated baseline glucose levels, and a prediabetes diagnosis in the medical record. These findings suggest the need for studies to evaluate physicians' reasons for different treatments and implementation of recommendations for type 2 diabetes prevention in patients with prediabetes in primary health care.
Authors
- Neri Alejandro Álvarez‐Villalobos (ORCID: https://orcid.org/0000-0001-5208-1429)
- Rosa María García-Hernández (ORCID: https://orcid.org/0000-0001-5731-1107)
- Fernando G. Ruiz-Hernández (ORCID: https://orcid.org/0000-0003-4912-180X)
- Sandra S. Rojo-Garza
- Gabriela Guadalupe Elizondo Omaña
- P. García de la Peña
- Andony I. Ramírez-Torres
Institutions
- Mexican Social Security Institute (MX)
- Universidad Autónoma de Nuevo León (MX)
- Mayo Clinic in Florida (US)
- University of Monterrey (MX)
Publication Details
- Journal
- Journal of Family Medicine and Primary Care
- Published
- 2024-11-01
- DOI
- https://doi.org/10.4103/jfmpc.jfmpc_552_24
- Primary Topic
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Type
- article
- Field-Weighted Citation Impact
- 0.00